Mikael Dolsten
Director · 6 filings · Latest: Sep 4, 2026
AGILENT TECHNOLOGIES, INC.
Apellis Pharmaceuticals, Inc.
ROCKET PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
A | Mikael Dolsten | Director | Sep 4, 2026 | Sale | $151.38 | 634 | $96.0K | 4,923.68 | |
A | Dolsten Mikael | — | Sep 4, 2026 | Proposed Sale | $151.38 | 634 | $96.0K | — | |
A | Mikael Dolsten | Director | May 29, 2026 | Sale | $135.42 | 1,600 | $216.7K | 5,548.385 | |
A | Dolsten Mikael | — | May 29, 2026 | Proposed Sale | $135.42 | 1,600 | $216.7K | — | |
A | Dolsten Mikael | — | Dec 1, 2025 | Proposed Sale | $149.81 | 2,600 | $389.5K | — | |
PFE | Dolsten Mikael | — | May 23, 2025 | Proposed Sale | $23.09 | 59,781 | $1.4M | — | |
PFE | Dolsten Mikael | — | May 5, 2025 | Proposed Sale | $23.87 | 55,000 | $1.3M | — |